semaglutide information sheet Patient Education Sheets, Weight Loss Forms (canva Template) Semaglutide Info Sheets Client Medical

Statements Data availability statement The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author

Combining genetic insights with clinical assessmentincluding your actual weight loss response at 4-8 weeks, gastrointestinal tolerance, and your provider's evaluationcan help guide more personalized dosing decisions and realistic outcome expectations

The benefits of blockbuster GLP-1 drugs like Ozempic, Wegovy, and Zepbound have become so convincing, theyve swayed even a spending-averse president and pharma-vilifying health secretary

In a phase 3 randomized, controlled clinical trial, participants treated with tirzepatide achieved an average weight loss of around 20% of their body weight over 72 weeks